Malignant tumor
Conditions
Interventions
Sponsors
Zhongnan Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate and sign the informed consent; 2. Aged > 18 years, < 70 years; 3. Routine imaging diagnosis of malignant tumor lesions and those who plan to undergo preoperative staging; 4. Patients with malignant tumor diagnosed by preoperative 18F-FDG PET/CT; 5. Willing and able to follow schedule visits, treatment plans and laboratory tests; 6. General biochemical tests (heart, liver, kidney, blood routine) and other indicators in clinical laboratories are in the normal range or have no clinical significance.
Exclusion criteria
Exclusion criteria: 1. Patients who plan to become pregnant within 6 months, or are pregnant or breastfeeding; 2. Those who are allergic to the test drug, have allergic constitution or are allergic to multiple drugs; 3. Those with poor general condition and the function of heart, lung, liver, kidney and other important organs cannot tolerate surgery; 4. Before the injection of 18F-FDG, the fasting blood glucose level exceeds 11.0 mmol/L; 5. Weight over 100 kg; 6. Patients with claustrophobia; 7. Those who cannot tolerate raising both arms and lying supine for 15-30 minutes; 8. The researchers believe that it is not suitable to participate in this clinical trial; 9. Those who have participated in clinical trials or are participating in other clinical trials within the past 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum Standard Intake Value;Mean Standard Intake Value;Sensitivity;Specificity;Positive predictive value;Negative predictive value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Diameter of Lesion;Metastatic Site; | — |
Countries
China
Contacts
Public ContactHe Yong
Zhongnan Hospital of Wuhan University
Outcome results
None listed